by George Schlich | Mar 1, 2015 | EPO
Background Applicants wishing to obtain patent protection in more than one country have various options for doing so. One strategy is to file a first application at, say, the UK Intellectual Property Office (UKIPO) or the European Patent Office (EPO), and then file a...
by Juliette Boynton | Feb 1, 2015 | Briefings, EPO, UPC
Questions When will the Unitary Patent System take effect? This is currently unknown. The system will come into force once the UPC Agreement has been ratified by 13 member states, which must include the UK, Germany and France. At present the “best guess” is mid-2016....
by Dr Andrew Clements | Jan 23, 2015 | EPO
Previously, most contracting states of the European Patent Convention (EPC) require the filing of a translation of the specification in order for a granted European patent to come into force in that state. This validation process and, in particular, the requirement...
by David Eyre | Jan 1, 2015 | EPO
Background Following C-34/10, any non-fertilised human ovum for which division and further development are stimulated by parthenogenesis was to be considered a “human embryo”. Such a non-fertilised and stimulated human ovum is called a parthenote. The CJEU’s ruling in...
by Juliette Boynton | Sep 1, 2014 | Briefings, UK
Until now, exceptions to patent infringement in the UK were limited, so manufacturers preparing for regulatory approval risked an infringement action. Legislation will come into force in the UK on 1 October 2014 that finally provides broad exemption from patent...
by David Eyre | Sep 1, 2014 | EPO
The scope for patenting stem cell-based inventions in Europe was dealt a blow by the judgement of the CJEU in Brüstle vs Greenpeace (C 34/10)1. The practical result of this judgement was that the earliest date from which the EPO would acknowledge that morally...
Recent Comments